From the *Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands; †College of Pharmacy, The University of Oklahoma College of Pharmacy, Tulsa, Oklahoma; ‡American Society of Health-System Pharmacists (ASHP) Research and Education Foundation, Bethesda, Maryland; §Center for Education and Research on Therapeutics of Musculoskeletal Disorders (CERTs), University of Alabama at Birmingham, Birmingham, Alabama; and ∥Division of Health Informatics and Implementation Science, Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts.
Correspondence: Michael J. Miller, RPh, DrPH, FAPhA, College of Pharmacy, The University of Oklahoma, 4502 East 41st St, Tulsa, OK 74135 (e-mail: [email protected]).
Dr Allison serves on the Medical Education External Review Panel for Pfizer. All other authors disclose no conflict of interest.
Supported, in part, by the Agency for Healthcare Research and Quality (AHRQ) Centers for Education and Research on Therapeutics cooperative agreement (U18HS016956).